You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Devices
New Study Finds That Masimo PVi Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery
Login
Username:

Password:


Related Headlines

Imvaria Shows Data Demonstrating Non-Invasive Digital Biomarker for Predicting Mortality in Interstitial Lung Diseases

Vicarious Surgical Promotes Mazzola to Chief Operating Officer

MicroPort CRM Receives US FDA Clearance for Alizea and Celea Pacemaker Systems

Abbott announces late-breaking outcome from AVEIR DR i2i IDE study

Asieris Pharmaceuticals announces strategic partnership with UroViu

Abbott's Assert-IQ Insertable Cardiac Monitor receives US FDA approval

Locate Bio's LDGraft Granted FDA Breakthrough Device Designation

NYBC Ventures Launches Fund with USD 50m from New York Blood Center

Foldax Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio

JADAK Launches Entire Series of ThingMagic M7e Modules

US FDA grants Breakthrough Device Designation for Singlera Genomics' PDACatch assay

Glaukos Receives FDA Acceptance of NDA Submission for iDose TR

Bambach Named Interim CFO at Tivic Health Systems

Pharmacolog extends distribution agreement with B. Braun Portugal

MIVI Neuroscience completes enrolment in Q Revascularisation System clinical trial

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2023